TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$120.55 USD
+1.58 (1.33%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $120.51 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TMDX 120.55 +1.58(1.33%)
Will TMDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
Countdown to TransMedics (TMDX) Q2 Earnings: Wall Street Forecasts for Key Metrics
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
Other News for TMDX
Morgan Stanley Raises Price Target for TMDX to $123 | TMDX Stock News
What TransMedics Just Taught Me About Trusting The Algorithm
TransMedics: Continued Strength Suggests Further Upside
TransMedics Group Inc (TMDX) Announces Inducement Grants to New Employees | TMDX stock news
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | TMDX Stock News